CHESTCHEST Journal PodcastNebulized vs IV Tranexamic Acid for Hemoptysis

Nebulized vs IV Tranexamic Acid for Hemoptysis


Originally aired: May 1, 2023

CHEST May 2023, Volume 163, Issue 5

Prakash Ranjan Mishra, MBBS, MD, joins CHEST Podcast Moderator, Alice Gallo de Moraes, MD, FCCP, to discuss whether the nebulized route of tranexamic acid administration reduces the amount of hemoptysis compared with the IV route in patients presenting to the ED with hemoptysis.


Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

Apple podcasts badge
Google podcast badge
Spotify podcast badge

Alice Gallo de Moraes, MD, FCCP